Vaccine Injury Law Project | IIT Chicago-Kent College of Law

Call Today 312-906-5072

565 West Adams Street, Suite 600, Chicago, IL 60661

Guillain-Barre Syndrome Vaccine Injury Compensation Lawyers

Virgina Guillain-Barre Syndrome Vaccine Injury Lawyer

National Vaccine Injury Attorneys Representing Clients with Guillain-Barre Syndrome

According to the Centers for Disease Control and Prevention (CDC), an estimated 3,000 to 6,000 people in the United States develop Guillain-Barre syndrome (GBS) each year. While rare, GBS causes the immune system to attack nerve cells in the body, leading to weakened muscles and at times, paralysis. For some people, Guillain-Barre syndrome is brought on by the use of seasonal influenza and other vaccines.

The Vaccine Injury Law Project is committed to helping children and adults who suffer from vaccine injuries such as Guillain-Barre syndrome. For more than ten years the firm has helped clients successfully pursue claims for injury and death caused by vaccination. Our team provides high-quality, compassionate representation at no cost to you or your loved one. If you believe GBS is linked to a vaccine, we are standing by to speak with you today.

Ed Kraus represented a client who contracted GBS after receiving an influenza vaccine. The effects of the injury lasted for more than six months. She was awarded a lump sum payment of $541,705.24 for life care expenses, lost earnings, and pain and suffering, as well as an annuity contract to provide payments for future care.

How Does Guillain-Barre Syndrome Affect People?

Development of GBS by vaccine is not common, but the risk is increased for those who have certain infections and in adults over 50 years of age. When GBS is the result of a vaccination, symptoms usually are present within hours or up to several weeks, according to the Vaccine Injury Table. The National Institutes of Health reports that GBS can:

  • Affect people of any age;
  • Cause weakness or paralysis within a short time;
  • Have a short or long-term recovery period;
  • Cause muscle relapse years after initial onset or symptoms; and
  • Be treated with various therapies, although there is no cure.

Decreased mobility, difficulty controlling facial movement, blood pressure fluctuation, and labored breathing are just some of the physical challenges of GBS. In addition, those affected may suffer from emotional distress. Treatment options to navigate the physiological and psychological impact can be costly. If you or a loved one has been diagnosed with GBS after the administration of an influenza vaccine, you may be eligible to pursue a claim.

What Vaccines Are Linked to Guillain-Barre Syndrome?

Proving causation in a vaccination injury or death case requires the assistance of a firm with experience bringing cases before the U.S. Court of Federal Claims. National Vaccine Compensation Program (VICP) cases are extremely complex. Such litigation requires skilled handling of medical data and lawyers who are adept at navigating strict federal procedures.

Our firm is a respected leader in representing clients impacted by various vaccines, including those that are linked to Guillain-Barre syndrome. Vaccines that may be connected to the onset of GBS include, but are not limited to:

GBS has four major sub-types: acute inflammatory demyelinating polyneuropathy (AIDP); acute motor axonal neuropathy (AMAN); acute motor and sensory neuropathy (AMSAN); and Fisher Syndrome (FS). Each sub-type of this syndrome has distinct characteristics. The level of detail it takes to make the connection between symptoms and a vaccine requires the help of a knowledgeable vaccine injury lawyer.

Contact a National Vaccine Injury Lawyer Now

We are a Chicago-based firm operating on the campus of Chicago-Kent College of Law at Illinois Tech. We provide no-cost legal representation for families who have a valid vaccine injury or death claim. Contact our office today to set up a complimentary consultation. Please call 312-906-5072 to speak with an attorney about your matter.

US Court of Federal Claims American Bar Association
Back to Top